Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 Apr;14(4):435-42.
doi: 10.1517/14728221003652471.

Targeting CXCR1/CXCR2 receptor antagonism in malignant melanoma

Bhawna Sharma  1 , Seema Singh, Michelle L Varney, Rakesh K Singh
Affiliations
Review

Targeting CXCR1/CXCR2 receptor antagonism in malignant melanoma

Bhawna Sharma et al. Expert Opin Ther Targets. 2010 Apr.

Abstract

Importance of the field: The incidence of malignant melanoma is increasing throughout the world and is currently rising faster than any other cancer in men and second only to lung cancer in women. Current strategies focused on systemic therapy for treatment of melanoma have shown no effect on survival. Therefore there is a pressing need for developing novel targeted therapeutics.

Areas covered in this review: Our goal is to provide an overview regarding targeting CXCR1/2 in malignant melanoma, the rationale behind these approaches and the future perspective.

What the reader will gain: This review illustrates our current understanding of CXCR1/2 receptor in melanoma progression and metastasis. We describe approaches that are being developed to block CXCR1/2 activation, including low-molecular-weight antagonists, modified chemokines and antibodies directed against ligands and receptors.

Take home message: The chemokine receptors CXCR1 and CXCR2 and their ligands play an important role in the pathogenesis of malignant melanoma. Recent reports demonstrated that CXCR1 is constitutively expressed in all melanoma cases irrespective of stage and grade, however, CXCR2 expression was restricted to aggressive melanoma tumors,. Furthermore, modulation of CXCR1/2 expression and/or activity has been shown to regulate malignant melanoma growth, angiogenesis and metastasis, suggesting CXCR1/2 targeting as a novel therapeutic approach for malignant melanoma.

PubMed Disclaimer

Figures

Figure 1
Figure 1
CXCR1- and CXCR2-dependent regulation of phenotypes associated with malignant melanoma progression and metastasis.
Figure 2
Figure 2
Autocrine and paracrine signaling and role of CXCR1 and CXCR2-dependent signaling in regulation of angiogenic phenotype. FGF: Fibroblast growth factor.
Figure 3
Figure 3
CXCR1/2 receptor signaling in regulation of malignant cell phenotypes. DAG: Diacylglycerol; FAK: Focal adhesion kinase; IP3: Inositol triphosphate; PKB: Protein kinase B; PLC: Phospholipase C; Pyk-2: Proline-rich tyrosine kinase 2; srcTPK: Src family tyrosine protein kinase.
See this image and copyright information in PMC

References

    1. Murphy PM, Baggiolini M, Charo IF, et al. International union of pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacol Rev. 2000;52:145–176. - PubMed
    1. Zlotnik A, Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity. 2000;12:121–127. - PubMed

    1. Balkwill F. Cancer and the chemokine network. Nat Rev Cancer. 2004;4:540–550. • An interesting recent review with updates on chemokineas and chemokines receptors in tumor growth and metastasis.

    1. Belperio JA, Keane MP, Burdick MD, et al. CXCR2/CXCR2 ligand biology during lung transplant ischemia-reperfusion injury. J Immunol. 2005;175:6931–6939. - PubMed
    1. Londhe VA, Belperio JA, Keane MP, et al. CXCR2/CXCR2 ligand biological axis impairs alveologenesis during dsRNA-induced lung inflammation in mice. Pediatr Res. 2005;58:919–926. - PubMed

Publication types

MeSH terms